|
Index of reports
> Serious Reactions (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vistide (Cidofovir) serious reactions. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vistide side effects in male
Reported by a physician from Belgium on 2012-08-01
Patient: male
Reactions: Therapeutic Response Decreased, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Aranesp
Dosage: 500 unknown, q3wk
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-01
End date: 2012-04-01
Probenecid
Dosage: unk
Indication: Nephropathy Toxic
Start date: 2011-11-01
End date: 2012-04-01
Vistide
Dosage: unk
Indication: Cytomegalovirus Infection
Start date: 2011-11-01
End date: 2012-04-01
Other drugs received by patient: Mabthera; Solian; Medrol; Omeprazole; Neoral
Possible Vistide side effects in male
Reported by a physician from Belgium on 2012-07-25
Patient: male
Reactions: Therapeutic Response Decreased, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Aranesp
Dosage: 500 unknown, q3wk
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-01
End date: 2012-04-01
Probenecid
Dosage: unk
Indication: Nephropathy Toxic
Start date: 2011-11-01
End date: 2012-04-01
Vistide
Dosage: unk
Indication: Cytomegalovirus Infection
Start date: 2011-11-01
End date: 2012-04-01
Other drugs received by patient: Medrol; Solian; Mabthera; Omeprazole; Neoral
Possible Vistide side effects in 37 year old male
Reported by a physician from Belgium on 2012-07-04
Patient: 37 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Therapeutic Response Decreased, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Aranesp
Dosage: 500 mug, q3wk
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-01
Probenecid
Dosage: unk
Indication: Nephropathy Toxic
Start date: 2011-11-01
End date: 2012-04-01
Vistide
Dosage: unk
Indication: Cytomegalovirus Infection
Start date: 2011-11-01
End date: 2012-04-01
Other drugs received by patient: Mabthera; Medrol; Solian; Omeprazole; Neoral; Mabthera
Possible Vistide side effects in 37 year old male
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-06-26
Patient: 37 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Therapeutic Response Decreased, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Aranesp
Dosage: 500 mug, q3wk
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-01
Probenecid
Dosage: unk
Indication: Nephropathy Toxic
Start date: 2011-11-01
End date: 2012-04-01
Vistide
Dosage: unk
Indication: Cytomegalovirus Infection
Start date: 2011-11-01
End date: 2012-04-01
Other drugs received by patient: Solian; Medrol; Mabthera; Neoral; Omeprazole; Mabthera
Possible Vistide side effects in 23 year old male
Reported by a physician from Germany on 2012-06-14
Patient: 23 year old male
Reactions: Drug Ineffective FOR Unapproved Indication
Drug(s) suspected as cause:
Vistide
Dosage: 5 mg/kg, q2wk
Vistide
Dosage: 5 mg/kg, q1wk
Indication: Skin Papilloma
Other drugs received by patient: Aspirin; Fluorouracil; Probenecid
Possible Vistide side effects in female
Reported by a physician from Germany on 2012-03-23
Patient: female
Reactions: Lung Disorder, Cardiac Disorder, Pericardial Effusion
Drug(s) suspected as cause:
Vistide
|
